Brain iron disorders

Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics

Volumn , Issue , 2005, Pages 880-889

  Kono, Satoshi ^a   Miyajima, Hiroaki ^a   Gitlin, Jonathan D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745752596     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544873.061     Document Type: Chapter

References (68)

1. Abboud, S. & Haile, D. J. (2000). A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275, 19906-12.
2. Andrews, N. C. (2000). Iron metabolism: iron deficiency and iron overload. Annu. Rev. Genom. Hum. Genet., 1, 75-98.
3. Andrews, N. C. (2002). A genetic view of iron homeostasis. Semin. Hematol. 39, 227-34.
4. Askwith, C. D., Eide, A., Van Ho, P. S. et al. (1994). The FET3 gene of S. cerevisiae encodes a multicopper oxidase required for ferrous iron uptake. Cell, 76, 403-10.
5. Bosio, S., De Gobbi, M., Roetto, A. et al. (2002). Anemia and iron overload due to compound heterozygosity for novel ceruloplasmin mutations. Blood, 100, 2246-8.
6. Calabrese, L., Carbonaro, M. & Musci, G. (1989). Presence of coupled trinuclear copper cluster in mammalian ceruloplasmin is essential for efficient electrontransfer tooxygen. J.Biol.Chem., 264, 6183-7.
7. Craven, C. M., Alexander, J., Eldridge, M., Kushner, J. P. Bernstein, S., & Kaplan, J. (1987). Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis. Proc.Natl Acad. Sci., USA, 84, 3457-61.
8. Crompton, D. E., Chinnery, P. F., Fey, C. et al. (2002). Neuroferritinopathy: a window on the role of iron in neurodegeneration. Blood CellsMol. Dis., 29, 522-31.
9. Curtis, A. R., Fey, C., Morris, C. M. et al. (2001). Mutation in the gene encoding ferritin light polypeptide causes dominant adultonset basal ganglia disease. Nat. Genet., 28, 350-4.
10. Daimon, M., Kato, T., Kawanami, T. et al. (1995a). Anonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus.Biochem.Biophys.Res.Commun., 217, 89-95.
11. Daimon, M., Yamatani, K., Igarashi, M. et al. (1995b). Fine structure of the human ceruloplasmin gene. Biochem. Biophys. Res. Commun., 208, 1028-35.
12. Daimon, M., Moriai, S., Susa, S., Yamatani, K., Hosoya, T. & Kato, T. (1999). Hypocaeruloplasminaemia with heteroallelic caeruloplasmin gene mutation: MRI of the brain. Neuroradiology, 41, 185-7.
13. Daimon, M., Susa, S., Ohizumi, T. et al. (2000). A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM). Tohoku J. Exp. Med., 191, 119-25.
14. Donovan, A., Brownlie, A., Zhou, Y. et al. (2000). Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature, 403, 776-81.
15. Fortna, R. R., Watson, H. A. & Nyquist, S. E. (1999). Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed by rat Sertoli cells and is concentrated in detergent-insoluble membrane fractions. Biol. Reprod., 61, 1042-9.
16. Gitlin, J. D. (1998). Aceruloplasminemia. Pediatr. Res., 44, 271-6.
17. Harris, Z. L., Durley, A. P., Man, T. K. & Gitlin, J. D. (1999). Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl Acad. Sci., USA, 96, 10812-17.
18. Harris, Z. L., Takahashi, Y., Miyajima, H., Serizawa, M., MacGillivray, R. T. & Gitlin, J. D. (1995). Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc.Natl Acad. Sci., USA, 92, 2539-43.
19. Harris, Z. L., Migas, M. C., Hughes, A. E., Logan, J. L. & Gitlin, J. D. (1996). Familial dementia due to a frameshift mutation in the caeruloplasmin gene. Quart. J.Med., 89, 355-9.
20. Harris, Z. L., Klomp, L.W. & Gitlin, J.D. (1998). Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am. J. Clin. Nutr., 67, 972S-7S.
21. Hayflick, S. J., Westaway, S. K., Levinson, B. et al. (2003). Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N. Engl. J.Med., 348, 33-40.
22. Hellman, N. E. & Gitlin, J.D. (2002). Ceruloplasmin metabolismand function. Annu. Rev. Nutr., 22, 439-58.
23. Hellman, N. E., Schaefer, M., Gehrke, S. et al. (2000). Hepatic iron overload in aceruloplasminaemia. Gut, 47, 858-60.
24. Hellman, N. E., Kono, S., Mancini, G. M., Hoogeboom, A. J., De Jong, G. J. & Gitlin, J. D. (2002a). Mechanisms of copper incorporation into human ceruloplasmin. J. Biol. Chem., 277, 46632-8.
25. Hellman, N. E., Kono, S., Miyajima, H. & Gitlin, J. D. (2002b). Biochemical analysis of a missense mutation in aceruloplasminemia. J. Biol. Chem., 277, 1375-80.
26. Jeong, S. Y. & David, S. (2003). GPI-anchored ceruloplasmin is requiredfor ironeffluxfromcells in the centralnervoussystem. J. Biol. Chem.
27. Kaneko, K., Yoshida, K., Arima, K. et al. (2002). Astrocytic deformity and globular structures are characteristic of the brains of patients with aceruloplasminemia. J. Neuropathol. Exp. Neurol., 61, 1069-77.
28. Kaplan, J. (2002a). Mechanisms of cellular ironacquisition: another iron in the fire. Cell, 111, 603-6.
29. Kaplan, J. (2002b). Strategy and tactics in the evolution of iron acquisition. Semin. Hematol., 39, 219-26.
30. Kato, T., Daimon, M., Kawanami, T., Ikezawa, Y., Sasaki, H. & Maeda, K. (1997). Islet changes in hereditary ceruloplasmin deficiency. Hum. Pathol., 28, 499-502.
31. Kaur, D., Yantiri, F., Rajagopalan, S. et al. (2003). Genetic or pharmacological ironchelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease. Neuron, 37, 899-909.
32. Klomp, L. W. & Gitlin, J. D. (1996). Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum. Mol. Genet., 5, 1989-96.
33. Klomp, L. W., Farhangrazi, Z. S., Dugan, L. L. & Gitlin, J. D. (1996). Ceruloplasmin gene expression in the murine central nervous system. J. Clin. Invest., 98, 207-15.
34. Kohno, S., Miyajima, H., Takahashi, Y. & Inoue, Y. (2000). Aceruloplasminemia with a novel mutation associated with parkinsonism. Neurogenetics, 2, 237-8.
35. Koschinsky, M. L., Chow, B. K., Schwartz, J., Hamerton, J. L. & MacGillivray, R. T. (1987). Isolation and characterization of a processed gene for human ceruloplasmin. Biochemistry, 26, 7760-7.
36. Lee, G. R., Nacht, S., Lukens, J. N. & Cartwright, G. E. (1968). Iron metabolism in copper-deficient swine. J. Clin. Invest., 47, 2058-69.
37. Lee, P., Gelbart, T., West, C., Halloran, C. & Beutler, E. (2002). Seeking candidate mutations that affect iron homeostasis. Blood Cells Mol. Dis., 29, 471-87.
38. Logan, J. I., Harveyson, K. B., Wisdom, G. B., Hughes, A. E. & Archbold, G. P. (1994). Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus. Quart. J.Med., 87, 663-70.
39. Loreal, O., Turlin, B., Pigeon, C. et al. (2002). Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J. Hepatol., 36, 851-6.
40. McKie, A. T., Marciani, P., Rolfs, A. et al. (2000). A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation.Mol. Cell, 5, 299-309.
41. Miyajima, H., Nishimura, Y., Mizoguchi, K., Sakamoto, M., Shimizu, T. & Honda, N. (1987). Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology, 37, 761-7.
42. Miyajima, H., Takahashi, Y., Kamata, T., Shimizu, H., Sakai, N. & Gitlin, J. D. (1997). Use of desferrioxamine in the treatment of aceruloplasminemia. Ann. Neurol., 41, 404-7.
43. Miyajima, H., Fujimoto, M., Kohno, S., Kaneko, E. & Gitlin, J. D. (1998). CSF abnormalities in patients with aceruloplasminemia. Neurology, 51, 1188-90.
44. Miyajima, H., Kohno, S., Takahashi, Y., Yonekawa, O. & Kanno, T. (1999). Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology, 53, 617-19.
45. Miyajima, H., Kono, S., Takahashi, Y., Sugimoto, M., Sakamoto, M. & Sakai, N. (2001). Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology, 57, 2205-10.
46. Miyajima, H., Kono, S., Takahashi, Y. & Sugimoto, M. (2002). Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains. Blood Cells Mol. Dis., 29, 433-8.
47. Miyajima, H., Takahashi, Y. & Kono, S. (2003). Aceruloplasminemia, an inherited disorder of iron metabolism. Biometals, 16, 205- 13.
48. Montosi, G., Donovan, A., Totaro, A. et al. (2001). Autosomaldominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest., 108, 619-23.
49. Morita, H., Ikeda, S., Yamamoto, K. et al. (1995). Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann. Neurol., 37, 646-56.
50. Nittis, T. & Gitlin, J. D. (2002). The copper-iron connection: hereditary aceruloplasminemia. Semin. Hematol., 39, 282-9.
51. Njajou, O. T., Vaessen, N., Joosse, M. et al. (2001). A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat. Genet., 28, 213-14.
52. Okamoto, N., Wada, S., Oga, T. et al. (1996). Hereditary ceruloplasmin deficiency with hemosiderosis. Hum. Genet., 97, 755-8.
53. Osaki, S., Johnson, D. A. & Frieden, E. (1966). The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem., 241, 2746-51.
54. Osaki, S., Johnson, D. A. & Frieden, E. (1971). The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J. Biol. Chem., 246, 3018-23.
55. Patel, B.N. & David, S. (1997). Anovel glycosylphosphatidylinositolanchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem., 272, 20185-90.
56. Patel, B. N., Dunn, R. J. & David, S. (2000). Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J. Biol. Chem., 275, 4305-10.
57. Patel, B. N., Dunn, R. J., Jeong, S. Y., Zhu, Q., Julien, J. P. & David, S. (2002). Ceruloplasmin regulates ironlevels in theCNSandprevents free radical injury. J. Neurosci., 22, 6578-86.
58. Roeser, H. P., Lee, G. R., Nacht, S. & Cartwright, G. E. (1970). The role of ceruloplasmin in iron metabolism. J. Clin. Invest., 49, 2408-17.
59. Sato, M. & Gitlin, J. D. (1991). Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J. Biol. Chem., 266, 5128-34.
60. Sipe, J. C., Lee, P. & Beutler, E. (2002). Brain iron metabolism and neurodegenerative disorders. Dev. Neurosci., 24, 188-96.
61. Takahashi, Y., Miyajima, H., Shirabe, S., Nagataki, S., Suenaga, A. & Gitlin, J. D. (1996). Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum.Mol. Genet., 5, 81-4.
62. Takeuchi, Y., Yoshikawa, M., Tsujino, T. et al. (2002). A case of aceruloplasminaemia: abnormal serum ceruloplasmin protein without ferroxidase activity. J. Neurol. Neurosurg. Psychiatry, 72, 543-5.
63. Torti, F. M. & Torti, S. V. (2002). Regulation of ferritin genes and protein. Blood, 99, 3505-16.
64. Vulpe, C. D., Kuo, Y. M., Murphy, T. L. et al. (1999). Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet., 21, 195-9.
65. Yazaki, M., Yoshida, K., Nakamura, A. et al. (1998). A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis. J. Neurol. Sci., 156, 30-4.
66. Yonekawa, M., Okabe, T., Asamoto, Y. & Ohta, M. (1999). A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma. Eur. Neurol., 42, 157-62.
67. Yoshida, K., Furihata, K., Takeda, S. et al. (1995). A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet., 9, 267-72.
68. Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J. & Hayflick, S. J. (2001). A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet., 28, 345-9.